Safety Alerts Saves Lives
Safety Alerts  
 
Home Privacy About Us Contact Us Change Preferences

SafetyAlerts
January 30, 2002

GlaxoSmithKline Has Recalled Anectine and Retrovir

Zebulon, NC (SafetyAlerts) - The Food and Drug Administration (FDA) said that GlaxoSmithKline has recalled Anectine (succinylcholine chloride) Injection and Retrovir (zidovudine) IV Infusion.

PRODUCT
Anectine (succinylcholine chloride) Injection, 200 mg/10mL (20mg/mL),10 mL Multiple Dose vial, Rx only, Recall # D-088-2;

Retrovir (zidovudine) IV Infusion, sterile, 10 mL/mL, 20 mL single use vial, Tray of 10 vials, Rx only, Recall # D-089-2.

CODE
Anectine Injection - Lot Number 0L2080;
Retrovir IV Infusion - Lot Number 9K2300.

RECALLING FIRM/MANUFACTURER
Recalling Firm: GlaxoSmithKline Zebulon, NC, by letter on Nov. 5, 2001.

Manufacturer: DSM Catalytica Pharmaceuticals, Greenville, NC. Firm initiated recall is ongoing.

REASON
Lack of assurance of sterility (glassware may exhibit cracks).

VOLUME OF PRODUCT IN COMMERCE
Anectine - 8,162 units and Retrovir - 1,062 units.

DISTRIBUTION
Nationwide
.

 
Selected Recent Recalls


Health Professional:

Did you know?
During 2000 there were over
1050 products recalled in the United
States for safety reasons!

How many did you hear about?

Sign-up for SafetyAlerts by Email -
The free internet newsletter that could
some day literally save your life - or
the life of someone you know.

   
   

 

The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.